Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



3 Keys to Turn Around This Struggling Device Maker

Investors can be forgiven in thinking that Boston Scientific's (NYSE: BSX  ) on the right track. After all, this medical device stock has soared more than 58% year-to-date, rising as one of the top performers in the medical device industry in 2013. Yet underneath that rise in shares, Boston Scientific's hiding a struggling business and lagging sales.

Boston Scientific's interventional cardiology and cardiac rhythm management businesses -- its two top segments that make up more than 50% of total company revenue -- have slumped recently and saw sales decline in 2012. With pricing pressures ramping up and tough competition abounding, this company's struggling to turn its financials around. What does Boston Scientific need to do to look good as an investment again? Motley Fool contributor Dan Carroll tells you what Boston Scientific needs to focus on if this company wants to secure a bright future and reward shareholders with more of this year's stock gains.

Boston Scientific has performed well in the drug-eluting stent market, but no company's thriving in this industry like Abbott Labs. This company has changed forever, however, after losing its branded pharmaceutical business to a spinoff. If you're a current investor, or might be buying shares soon, make sure you truly understand the stock by reading The Motley Fool's brand new premium report on Abbott Labs. The report outlines all of the must-know opportunities and risks, along with a full year of analyst updates to keep you up to speed. Best of all, you can claim this report today by clicking here now.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2502572, ~/Articles/ArticleHandler.aspx, 9/29/2016 8:28:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,143.45 -195.79 -1.07%
S&P 500 2,151.13 -20.24 -0.93%
NASD 5,269.15 -49.39 -0.93%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 4:01 PM
BSX $23.30 Down -0.45 -1.89%
Boston Scientific CAPS Rating: ***
ABT $41.44 Down -0.85 -2.01%
Abbott Laboratorie… CAPS Rating: *****
MDT $85.40 Down -1.34 -1.54%
Medtronic CAPS Rating: *****
STJ $78.96 Down -0.77 -0.97%
St. Jude Medical CAPS Rating: **
SYK $115.70 Down -1.61 -1.37%
Stryker CAPS Rating: *****